TKL Research has selected Medidata Solution’s CTMS, a software-as-a-service (SaaS) clinical trial management system, as part of an initiative to expand its clinical trial operations. Medidata CTMS allows TKL to identify sites that can rapidly enroll patients by measuring actual recruitment milestones against site-forecasted times. The study metrics captured by Medidata CTMS are being used to evaluate resource deployment and streamline processes in an effort to meet the needs of TKL’s multisystem, multi-trial operations.

Kevin Vernarec, TKL’s vice president of operational excellence, said, “We expect that the robust functionalities of Medidata CTMS will allow us to determine where opportunities lie and track improvement metrics over time. We are aiming to reduce study start-up time by two to four weeks, with no added costs, just efficiency improvements — giving our clients a competitive edge.”

“Medidata CTMS helps evaluate operational effectiveness, implement changes and measure their impact quickly,” said Glen de Vries, president of Medidata Solutions. “Our flexible, modular system provides support to individual functions as well as the ability to review data from across an organization.”